Zacks Investment Research
26 May 2026, 16:46 UTC · 2h ago
Source · https://www.zacks.com/stock/news/2926930/broad-based-medsurg-growth-likely-to-aid-mdt-s-q4-performance?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_preview-2926930
Read source
Search tags
Story key points
4 claims · impact-rated
Medtronic is scheduled to release its fourth-quarter fiscal 2026 results on June 3. — Earnings releases are primary catalysts for short-term stock price volatility.
+0.30The Zacks Consensus Estimate for Medtronic's fourth-quarter earnings is $1.56 per share, representing a 3.7% decrease from the prior year. — A projected year-over-year decline in earnings typically weighs on investor sentiment.
-0.20The Zacks Consensus Estimate for fourth-quarter revenues is $9.66 billion, indicating 8.3% year-over-year growth. — Strong top-line growth suggests healthy demand for the company's products despite earnings pressure.
+0.20Medtronic has beat earnings estimates in each of the trailing four quarters, with an average beat of 2.76%. — A consistent track record of beats increases the likelihood of a positive surprise in the upcoming report.
Impact vectors
2 dimensions · 9 clusters
Market reaction
10 bid · 10 offered
Ticker attribution
Model heads
The company has a track record of beating earnings estimates and shows strong growth momentum in Cardiac Ablation and Structural Heart segments.
No ticker relationship head found.
